Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration is seeking public input on safety requirements and clinical trial designs for ibogaine, a psychedelic compound being investigated for opioid use …
FDA Seeks Input on Ibogaine Trials Amid Safety Concerns Read More
MALVERN, PA — Psych Congress 2026 will devote five days of programming Sept. 15-19 in New Orleans to psychedelic therapies as federal policy, clinical research and patient demand push psychiatrists …
Psych Congress Expands Psychedelics Focus as Policy Shifts Read More
WASHINGTON, D.C. — The Department of Veterans Affairs and the Department of Health and Human Services signed an agreement to coordinate research and regulatory efforts aimed at accelerating the evaluation …
VA, HHS Expand Psychedelic Research for Veterans Read More
WASHINGTON, D.C. — Federal health officials are investing up to $139.4 million in new research to accelerate the development of mental health treatments, including emerging therapies such as digital tools, …
$139M Mental Health Push Aims to Speed New Treatments Read More
WILMINGTON, DE — NRx Pharmaceuticals (Nasdaq: NRXP) said it supports an executive order signed April 18, 2026, directing federal agencies to accelerate research and regulatory pathways for treatments targeting serious …
NRx Pharmaceuticals Responds to Executive Order on Mental Health Treatments Read More